# Study to Assess the Patterns of Use of REKOVELLE® in Naïve Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures

> **NCT03393780** · — · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 1018 (actual)

## Conditions studied

- Controlled Ovarian Stimulation

## Interventions

- **DRUG:** Follitropin Delta

## Key facts

- **NCT ID:** NCT03393780
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-16
- **Primary completion:** 2020-04-17
- **Final completion:** 2020-07-17
- **Target enrollment:** 1018 (ACTUAL)
- **Last updated:** 2023-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03393780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03393780, "Study to Assess the Patterns of Use of REKOVELLE® in Naïve Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03393780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*